Evolution of protective SARS-CoV-2-specific B and T cell responses upon vaccination and Omicron breakthrough infection

接种疫苗和奥密克隆疫苗突破感染后SARS-CoV-2特异性B细胞和T细胞保护性反应的演变

阅读:2
作者:Mohamed I M Ahmed ,Sebastian Einhauser ,Clemens Peiter ,Antonia Senninger ,Olga Baranov ,Tabea M Eser ,Manuel Huth ,Laura Olbrich ,Noemi Castelletti ,Raquel Rubio-Acero ,George Carnell ,Jonathan Heeney ,Inge Kroidl ,Kathrin Held ,Andreas Wieser ,Christian Janke ,Michael Hoelscher ,Jan Hasenauer ,Ralf Wagner ,Christof Geldmacher

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron breakthrough infection (BTI) induced better protection than triple vaccination. To address the underlying immunological mechanisms, we studied antibody and T cell response dynamics during vaccination and after BTI. Each vaccination significantly increased peak neutralization titers with simultaneous increases in circulating spike-specific T cell frequencies. Neutralization titers significantly associated with a reduced hazard rate for SARS-CoV-2 infection. Yet, 97% of triple vaccinees became SARS-CoV-2 infected. BTI further boosted neutralization magnitude and breadth, broadened virus-specific T cell responses to non-vaccine-encoded antigens, and protected with an efficiency of 88% from further infections by December 2022. This effect was then assessed by utilizing mathematical modeling, which accounted for time-dependent infection risk, the antibody, and T cell concentration at any time point after BTI. Our findings suggest that cross-variant protective hybrid immunity induced by vaccination and BTI was an important contributor to the reduced virus transmission observed in Bavaria in late 2022 and thereafter.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。